Page 2 - சவுதி உணவு மருந்து அதிகாரம் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from சவுதி உணவு மருந்து அதிகாரம். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In சவுதி உணவு மருந்து அதிகாரம் Today - Breaking & Trending Today

Datametrex Secures Exclusive Rights to Distribute FDA, EUA and CE Approved COVID-19 Saliva Kit


Datametrex Secures Exclusive Rights to Distribute FDA, EUA and CE Approved COVID-19 Saliva Kit
Datametrex AI Limited is pleased to announce that it has secured exclusive rights to sell and distribute COVID-19 saliva kit manufactured by WIZCHEM CO., LTD. in Canada and Saudi Arabia, and non-exclusive rights for the United States of America, United Kingdom, and European Unions.The Company signed the distribution agreement on January 28, 2021, to sell the COVICHEK™ Saliva DNARNA Collection Kit and COVICHEK™ …
 Datametrex AI Limited (TSXV: DM) (FSE: D4G) (OTC Pink: DTMXF) (the “Company” or “Datametrex“) is pleased to announce that it has secured exclusive rights to sell and distribute COVID-19 saliva kit manufactured by WIZCHEM CO., LTD. (“WIZCHEM”) in Canada and Saudi Arabia, and non-exclusive rights for the United States of America, United Kingdom, and European Unions. ....

Saudi Arabia , United States , South Korea , United Kingdom , Kingdom Of Saudi Arabia , Saud Arabia , Marshall Gunter , Human Services , Saudi Food Drug Authority , European Commission , European Free Trade Association , Drug Administration , Datametrex Ai Limited , Us Food Drug Administration , Company Or Datametrex , European Union , Department Of Health , Health Canada , Venture Exchange , Regulation Services Provider , Viral Transport Medium , Saliva Kit , Good Manufacturing Practice , Saudi Food , Drug Authority , Coronavirus Disease ,

MENA Biologics & Biosimilars Market to Surpass US$ 623.7 by 2027, Says Coherent Market Insights (CMI)


US$ 442.5 million in 2020 and is expected to exhibit a CAGR of 3.9%
during the forecast period (2020-2027).
Key Trends and Analysis:
The
MENA biologics & biosimilars market is expected to witness significant growth, owing to increasing prevalence of Age-related Macular Degeneration (AMD). For instance, according to the study in Saudi Medical Journal 2015, in Saudi Arabia, AMD represents 3.3% of the major causes of blindness in individuals older than 50 years.
The increasing approval and new drug launches are expected to propel the market growth. For instance, in 2017, Swedish Orphan Biovitrum AB (Sobi) received Saudi Food & Drug Authority (SFDA) approval for Elocta (efmoroctocog alfa), a recombinant human factor VIII Fc-fusion protein with an extended half-life, for the treatment of hemophilia A. ....

United States , United Kingdom , World Health Organization , Al Qahirah , Saudi Arabia , Asia Pacific , Chugai Pharmaceutical Co Ltd , Ministry Of Health Prevention Mo , Regeneron Pharmaceuticals Inc , Saudi Food Drug Authority , Takeda Pharmaceutical Company , Pfizer Inc , Amgen Inc , Roche Group , Business Development , Coherent Market Insights , Age Related Macular Degeneration , Saudi Medical Journal , Swedish Orphan Biovitrum , Saudi Food , Drug Authority , Middle East , Research Report , Market Takeaways , Bayti Home , Regeneron Pharmaceuticals ,

Datametrex Secures Exclusive Rights For COVID-19 Saliva Test Kit In Canada, Saudi Arabia


Datametrex AI (TSXV: DM) has secured further test kits for its COVID-19 testing operation. The company this morning announced that it has secured exclusive rights to sell and distribute a COVID-19 saliva kit manufactured by Wizchem in both Canada and Saudi Arabia, as well as non-exclusive rights for the United Stated, the European Union, and the United Kingdom.
Labelled as the COVICHEK Saliva DNA/RNA Collection Kit, as well as the associated transport medium, the test kit has secured US FDA Emergency Use Authorization, as well as the CE Mark designation which enables sales within the European Union. The product is also GMP compliant. ....

Saudi Arabia , United States , United Kingdom , South Korea , Kingdom Of Saudi Arabia , Marshall Gunter , Canacom Group , Saudi Food Drug Authority , European Union , Health Canada , United Stated , Use Authorization , Saudi Food , Drug Authority , Deep Dive , சவுதி அரேபியா , ஒன்றுபட்டது மாநிலங்களில் , ஒன்றுபட்டது கிஂக்டம் , தெற்கு கொரியா , கிஂக்டம் ஆஃப் சவுதி அரேபியா , மார்ஷல் குண்டர் , சவுதி உணவு மருந்து அதிகாரம் , ஐரோப்பிய தொழிற்சங்கம் , ஆரோக்கியம் கனடா , ஒன்றுபட்டது கூறினார் , பயன்பாடு அங்கீகாரம் ,

MEED | Egypt to get 500,000 Covid-19 jab doses by year-end


Recoveries: 351,722
Actions to slow the spread of Covid-19:
17 December: Vaccination drive begins with Health Minister Tawfiq al-Rabiah receiving the Covid-19 jab in Riyadh. 
15 December: Health ministry starts registrations to receive Covid-19 vaccine. Vaccination will be free and is divided into three stages, the first of which will cover citizens and residents who are over 65 years old; professionals who are most vulnerable to infection; people who are obese and have a body mass of more than 40; those who have a lack of immunity or take immunosuppressive drugs; and those who have two or more chronic diseases, such as asthma, diabetes, chronic kidney disease and chronic obstructive pulmonary disease. The second stage includes citizens and residents who are over 50 years old, the rest of health practitioners, and those who have one chronic disease. The last stage is for all citizens and residents who wish to take the vaccine. ....

Al Madinah , Saudi Arabia , United Arab Emirates , El Oued , United Kingdom , Zhang Xu , Rabat Saleemmour Zaëmo , Ad Daw Ah , Souss Massa Dramo , Ar Riya , Uttar Pradesh , Libya General , Abu Dhabi , Abuz Aby , El Tarf , Islamic Republic Of Iran , Nicolas Chammas , Mohammed Al Saeedi , King Mohammed , Hassan Rouhani , Hachemi Louzir , Institut Pasteur , Azeddine Ibrahimi , Akissa Bahri , Hamad Hassan , Abdullah Al Bader ,